Page 14 - Mark Horowitz News Today

A review of research on antidepressant efficacy finds that an unfavorable risk-to-benefit ratio.

Do we take enough account of total drug exposure time when devising antidepressant tapering strategies?

New review advocates for a ‘more cautious prescribing practice’

Millions of people take antidepressants each day, but a major new review of the data brings up some concerns with how the drugs are currently prescribed. 

New York Film Academy (NYFA) MFA Filmmaking alum Hongyu “Neo” Li was selected as the Development Executive and In-House Writer for Starlight Media. The

Experts say the pandemic is transitioning into an endemic, mostly for the better unless you’re still unvaccinated.

MIA's Amy Biancolli interviews Adele Framer, founder of SurvivingAntidepressants.org, about psychiatric drug withdrawal.

The remaining esketamine trial showed a statistically significant effect that did not meet clinical significance.

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

New guidance on how to taper and discontinue from psychiatric drugs from leading researchers Mark Horowitz and David Taylor.